Stay updated on Clinical Trial: Reboxetine in Narcolepsy & Cataplexy
Sign up to get notified when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.

Latest updates to the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. No changes to the study details or page functionality were observed.SummaryDifference0.1%

- Check26 days agoChange Detected- Removal of the government funding lapse notice from the page. The notice previously informed users about potential delays and directed readers to external sources for operating status updates.SummaryDifference0.4%

- Check40 days agoChange DetectedThe page shows a visual refresh with minor layout and header changes; core trial information (title, conditions, eligibility criteria, primary outcome, enrollment, and locations) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference6%

- Check77 days agoChange DetectedThe page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) have been removed.SummaryDifference0.9%

- Check91 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, indicating an updated release. The 'Back to Top' element was removed, a minor UI change.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial: Reboxetine in Narcolepsy & Cataplexy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.